Accession Number:

ADA509027

Title:

DoD Global Emerging Infections System Annual Report, Fiscal Year 2002

Descriptive Note:

Annual rept.

Corporate Author:

ARMED FORCES HEALTH SURVEILLANCE CENTER SILVER SPRING MD

Personal Author(s):

Report Date:

2002-01-01

Pagination or Media Count:

41.0

Abstract:

The events of and following September 11, 2001 brought into focus timely global surveillance for emerging infections as a cornerstone of national and global security. It became clear that public health infrastructure could no longer be a secondary consideration in national and local budgets, but that it is part of the foundation of our individual and collective well-being. The anthrax events of 2001 may have only harmed a small number of people in the United States but worldwide, even in developing countries that regularly cope with major naturally occurring outbreaks of infectious diseases, countries woke up with a start to the threat of bioterrorism. The emergence in China of SARS in late 2002 not only highlighted a new and serious threat in its own right but also reinforced that emerging infections that may emerge in one part of the world can rapidly cause devastating problems elsewhere. These events have all shown as prophetic those experts and government leaders who called for the establishment of DoD-GEIS in the early 1990s. Fiscal year 2002 was DoD-GEISs sixth year of funded operations. The DoD-GEIS central management hub coordinated activities with a core budget of 9 million. This was leveraged through an extensive network of partnerships within the DoD, with other US government agencies, and with many foreign governments and international agencies. These partnerships supported both domestic and foreign programs of surveillance, response, capacity building, and training. Many of these programs provided direct benefits to the global war on terrorism.

Subject Categories:

  • Medicine and Medical Research
  • Chemical, Biological and Radiological Warfare

Distribution Statement:

APPROVED FOR PUBLIC RELEASE